Glaukos Operating Income 2014-2024 | GKOS

Glaukos annual/quarterly operating income history and growth rate from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Glaukos operating income for the quarter ending September 30, 2024 was $-0.025B, a 11.96% decline year-over-year.
  • Glaukos operating income for the twelve months ending September 30, 2024 was $-0.132B, a 6.87% increase year-over-year.
  • Glaukos annual operating income for 2023 was $-0.129B, a 56.35% increase from 2022.
  • Glaukos annual operating income for 2022 was $-0.082B, a 150.4% increase from 2021.
  • Glaukos annual operating income for 2021 was $-0.033B, a 73.39% decline from 2020.
Glaukos Annual Operating Income
(Millions of US $)
2023 $-129
2022 $-82
2021 $-33
2020 $-124
2019 $-50
2018 $-13
2017 $-2
2016 $4
2015 $-10
2014 $-13
2013 $-14
Glaukos Quarterly Operating Income
(Millions of US $)
2024-09-30 $-25
2024-06-30 $-30
2024-03-31 $-39
2023-12-31 $-39
2023-09-30 $-28
2023-06-30 $-29
2023-03-31 $-33
2022-12-31 $-34
2022-09-30 $-22
2022-06-30 $-37
2022-03-31 $10
2021-12-31 $-18
2021-09-30 $11
2021-06-30 $-14
2021-03-31 $-12
2020-12-31 $-11
2020-09-30 $-12
2020-06-30 $-47
2020-03-31 $-53
2019-12-31 $-30
2019-09-30 $-12
2019-06-30 $-6
2019-03-31 $-2
2018-12-31 $2
2018-09-30 $-7
2018-06-30 $-4
2018-03-31 $-4
2017-12-31 $1
2017-09-30 $1
2017-06-30 $-4
2017-03-31 $0
2016-12-31 $0
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $-2
2015-09-30 $-2
2015-06-30 $-5
2015-03-31 $-1
2014-12-31 $-5
2014-09-30 $-2
2014-06-30 $-2
2014-03-31 $-4
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.520B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.963B 25.00
Intuitive Surgical (ISRG) United States $191.657B 100.20
Edwards Lifesciences (EW) United States $43.285B 27.49
Alcon (ALC) Switzerland $42.325B 28.32
IQVIA Holdings (IQV) United States $36.881B 20.32
IDEXX Laboratories (IDXX) United States $36.416B 42.88
DexCom (DXCM) United States $31.017B 46.71
Waters (WAT) United States $23.177B 34.27
STERIS (STE) Ireland $21.145B 24.34
SONOVA HOLDING (SONVY) Switzerland $19.889B 0.00
Hologic (HOLX) United States $17.436B 18.83
Fresenius Medical Care AG KGaA (FMS) Germany $14.025B 14.40
Sysmex ADR (SSMXY) Japan $12.739B 39.95
Globus Medical (GMED) United States $11.287B 28.58
Masimo (MASI) United States $9.351B 45.25
Penumbra (PEN) United States $9.298B 91.08
Teleflex (TFX) United States $8.663B 13.82
PROCEPT BioRobotics (PRCT) United States $4.758B 0.00
Integer Holdings (ITGR) United States $4.684B 26.55
Veracyte (VCYT) United States $3.331B 99.95
Inari Medical (NARI) United States $3.223B 0.00
LivaNova (LIVN) United Kingdom $2.717B 15.69
Nihon Kohden (NHNKY) Japan $2.514B 19.10
TransMedics (TMDX) United States $2.315B 73.39
Elekta AB (EKTAY) Sweden $2.239B 20.13
Tandem Diabetes Care (TNDM) United States $2.221B 0.00
Integra LifeSciences Holdings (IART) United States $1.853B 9.68
RxSight (RXST) United States $1.579B 0.00
Alphatec Holdings (ATEC) United States $1.369B 0.00
Artivion (AORT) United States $1.250B 82.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $1.025B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.859B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.709B 0.00
IRadimed (IRMD) United States $0.701B 37.88
Mesa Laboratories (MLAB) United States $0.700B 16.50
AxoGen (AXGN) United States $0.653B 0.00
Pacific Biosciences Of California (PACB) United States $0.641B 0.00
SiBone (SIBN) United States $0.596B 0.00
OrthoPediatrics (KIDS) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.496B 29.18
Treace Medical Concepts (TMCI) United States $0.492B 0.00
ClearPoint Neuro (CLPT) United States $0.460B 0.00
Tactile Systems Technology (TCMD) United States $0.449B 24.29
Delcath Systems (DCTH) United States $0.373B 0.00
AngioDynamics (ANGO) United States $0.361B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.231B 0.00
Alpha Tau Medical (DRTS) Israel $0.212B 0.00
Accuray (ARAY) United States $0.208B 0.00
Sight Sciences (SGHT) United States $0.198B 0.00
KORU Medical Systems (KRMD) United States $0.180B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.56
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
WORK Medical Technology Group (WOK) China $0.093B 0.00
Monogram Orthopaedics (MGRM) United States $0.092B 0.00
Vicarious Surgical (RBOT) United States $0.091B 0.00
LENSAR (LNSR) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.084B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00